Publication
Prognostic value of neutrophil-to-lymphocyte ratio (NLR) in metastatic castration-resistant prostate cancer (mCRPC) pts receiving a new agent (NA)- based third line treatment: Final results from a multicenter Italian study.
Orazio Caffo, Emilio Bria, Ugo De Giorgi, Marcello Tucci, Elisa Biasco, Lucia Fratino, Gaetano Facchini, Roberto Iacovelli, Giovanni Lo Re, Simone Scagnoli, Franco Morelli, Alessandro D'Angelo, Francesco Verderame, Enrico Campadelli, Riccardo Ricotta, Martina Napolitano, Donata Sartori, Nicolo Borsellino, Isabella Sperduti, Marco Maruzzo
Journal of Clinical Oncology, May 2017, American Society of Clinical Oncology (ASCO)
DOI: 10.1200/jco.2017.35.15_suppl.e16521